Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial benign hypercalcaemia.

C R Paterson, A Gunn

    Lancet (London, England)
    |July 11, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Familial benign hypercalcaemia (FBH) is a genetic condition that can mimic primary hyperparathyroidism. Recognizing FBH prevents unnecessary parathyroid surgery by analyzing calcium excretion patterns.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The healthy equine uterus harbors a distinct core microbiome plus a rich and diverse microbiome that varies with geographical location.

    Scientific reports·2022
    Same author

    A survey of producer practices and reproductive performance of containment and supplementary fed ewes.

    Australian veterinary journal·2021
    Same author

    The animal welfare aspects of surgical artificial insemination in the canine.

    Australian veterinary journal·2021
    Same author

    An interdisciplinary and catchment approach to enhancing urban flood resilience: a Melbourne case.

    Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2020
    Same author

    Identification and characterisation of anti - <i>Pseudomonas aeruginosa</i> proteins in mucus of the brown garden snail, <i>Cornu aspersum</i>.

    British journal of biomedical science·2019
    Same author

    Identifying risk factors associated with lameness in pasture-based dairy herds.

    Journal of dairy science·2016
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Genetics
    • Nephrology

    Background:

    • Familial benign hypercalcaemia (FBH), also known as familial hypocalciuric hypercalcaemia, affects multiple generations within families.
    • FBH can present with symptoms similar to primary hyperparathyroidism, including low-normal plasma phosphate and detectable parathyroid hormone levels.
    • Misdiagnosis has led to unnecessary parathyroid explorations in affected individuals.

    Purpose of the Study:

    • To differentiate familial benign hypercalcaemia (FBH) from primary hyperparathyroidism.
    • To highlight the importance of recognizing FBH to avoid invasive procedures.

    Main Methods:

    • Analysis of clinical data from a large family with multiple affected members across four generations.
    • Comparison of urinary calcium excretion patterns between FBH and primary hyperparathyroidism.

    Related Experiment Videos

  • Evaluation of indices reflecting tubular calcium handling, such as calcium excretion per litre of glomerular filtrate.

    • Main Results:

    • Urinary calcium excretion is significantly lower in FBH compared to primary hyperparathyroidism.
    • Indices of tubular calcium handling are more effective than 24-hour urinary calcium in distinguishing between FBH and primary hyperparathyroidism.
    • FBH may be more prevalent than commonly believed.

    Conclusions:

    • Accurate diagnosis of FBH is crucial to prevent unnecessary parathyroid surgery.
    • Assessing tubular calcium handling is key to differentiating FBH from primary hyperparathyroidism.
    • Increased awareness of FBH can improve patient outcomes and reduce healthcare costs.